Eplerenone

Ascites

Emma NilssonSmall moleculePhase 2Dormant

CCC

50/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 35/ 100
Competitive Position: 89/ 100

Competitive context

8 Active assets in the Ascites cohort.

Asset / Sponsor	Phase	Rating
Tolvaptan Konkuk University Medical Center	Phase 4	BBB
NORMAL HUMAN SERUM ALBUMIN Centro Medico Issemym	Phase 4	BBB
FUROSEMIDE University of Palermo	Phase 4	BB
Rifaximin Centre Hospitalier Universitaire de Besancon	Phase 4	BB
Spironolactone University of Padova	Phase 4	BB

View all 36 →

Same molecule, other indications

Eplerenone is also rated in:

abdominal obesity-metabolic syndromeDormant

B

Indicative ·

62 / 100

hypertensive disorderDormant

B

Indicative ·

61 / 100

Insulin ResistanceDormant

B

Indicative ·

58 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.